Corrigendum to “Lung function decline in people with serious mental illness: A call to action” [European Neuropsychopharmacology (2024) 41-46/ ENP-24-342] by Ruiz-Rull, Cristina, Jaén-Moreno, María José, del Pozo, Gloria Isabel, Camacho-Rodríguez, Cristina, Rodríguez-López, Marta, Rico-Villademoros, Fernando, Otero-Ferrer, José Luis, Feu, Nuria, Reyes-López, Micaela, Fiestas, Rosa M., Laguna-Muñoz, David, Jiménez-Peinado, Ana, Mannino, David, Vieta, Eduard, Sarramea, Fernando

Get full text

BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression: to be submitted to: European Neuropsychopharmacology by Schosser, Alexandra, Fischer-Hansal, Daniela, Swoboda, Marleen M, Ludwig, Birgit, Carlberg, Laura, Swoboda, Patrick, Kienesberger, Klemens, Bernegger, Alexandra, Fuxjäger, Monika, Zotter, Melanie, Schmelzle, Nicolas, Inaner, Michelle, Koller, Romina, Kapusta, Nestor D, Haslacher, Helmuth, Aigner, Martin, Kasper, Siegfried, Senft, Birgit

Get full text

Corrigendum to ‘Suicide-related thoughts and behavior and suicide death trends during the COVID-19 in the general population of Catalonia, Spain’ [European Neuropsychopharmacology 56 (2021) 4–12] by Pérez, V., Elices, M., Vilagut, G., Vieta, E., Blanch, J., Laborda-Serrano, E., Prat, B., Colom, F., Palao, D., Alonso, J.

Get full text

Corrigendum to ‘No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial’ [European Neuropsychopharmacology 53 (2021) 34–46] by Baune, Bernhard T., Sampson, Emma, Louise, Jennie, Hori, Hikaru, Schubert, K. Oliver, Clark, Scott R., Mills, Natalie T., Fourrier, Célia

Get full text

Erratum to “Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100–116]” by Van Assche, Evelien, Ramos-Quiroga, J. Antoni, Pariante, Carmine M., Sforzini, Luca, Young, Allan H., Flossbach, Yanina, Gold, Stefan M., Hoogendijk, Witte J.G., Baune, Bernhard T., Maron, Eduard

Get full text

Corrigendum to ‘BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression’ European Neuropsychopharmacology Volume 58, May 2022, Pages 103-108 by Schosser, Alexandra, Fischer-Hansal, Daniela, Swoboda, Marleen M., Ludwig, Birgit, Carlberg, Laura, Swoboda, Patrick, Kienesberger, Klemens, Bernegger, Alexandra, Fuxjäger, Monika, Zotter, Melanie, Schmelzle, Nicolas, Inaner, Michelle, Koller, Romina, Kapusta, Nestor D., Haslacher, Helmuth, Aigner, Martin, Kasper, Siegfried, Senft, Birgit

Get full text

Corrigendum to “Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]” by McCracken, James T., Anagnostou, Evdokia, Arango, Celso, Dawson, Geraldine, McPartland, James, Murphy, Declan, Pandina, Gahan, Veenstra-VanderWeele, Jeremy

Get full text

Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” by Manchia, Mirko, Vieta, Eduard, Smeland, Olav B., Altimus, Cara, Bechdolf, Andreas, Bellivier, Frank, Bergink, Veerle, Fagiolini, Andrea, Geddes, John R., Hajek, Tomas, Henry, Chantal, Kupka, Ralph, Lagerberg, Trine V., Licht, Rasmus W., Martinez-Cengotitabengoa, Monica, Morken, Gunnar, Nielsen, René E., González-Pinto, Ana, Reif, Andreas, Rietschel, Marcella, Ritter, Phillip, Schulze, Thomas G., Scott, Jan, Severus, Emanuel, Yildiz, Aysegul, Kessing, Lars Vedel, Bauer, Michael, Goodwin, Guy M., Andreassen, Ole A.

Get full text

Corrigendum to “Genetic origins of suicidality? A synopsis of genes in suicidal behaviours, with regard to evidence diversity, disorder specificity and neurodevelopmental brain transcriptomics [European Neuropsychopharmacology 37 (2020) 1–11]” by Sokolowski, Marcus, Wasserman, Danuta

Get full text

Editor’s note: The changing face of European Neuropsychopharmacology by Meyer-Lindenberg, Andreas

Get full text

Corrigendum to SU115 Interaction effects of childhood adversity and glutamatergic polygenic risk score on brain structure and cognition in schizophrenia [European Neuropsychopharmacology (2019) 29, S1268–S1342] by Saini, Suriati Mohamed, Mancuso, Sam, Liu, Chenxing, Mostaid, Md Shaki, Cropley, Vanessa, Van Rheenen, Tamsyn, Everall, Ian Paul, Bousman, Chad, Pantelis, Christos

Get full text

Erratum to “Functional roles of the glial glutamate transporter (GLAST) in emotional and cognitive abnormalities of mice after repeated phencyclidine administration” [European Neuropsychopharmacology (2019) 29, 914–924] by Uchida, Mizuki, Hida, Hirotake, Mori, Kentaro, Yoshimi, Akira, Kitagaki, Shinji, Yamada, Kiyofumi, Hiraoka, Yuichi, Aida, Tomomi, Tanaka, Kohichi, Ozaki, Norio, Noda, Yukihiro

Get full text

Corrigendum to "Lung function decline in people with serious mental illness: A call to action" European Neuropsychopharmacology (2024) 41-46/ ENP-24-342 by Ruiz-Rull, Cristina, Jaén-Moreno, María José, Del Pozo, Gloria Isabel, Camacho-Rodríguez, Cristina, Rodríguez-López, Marta, Rico-Villademoros, Fernando, Otero-Ferrer, José Luis, Feu, Nuria, Reyes-López, Micaela, Fiestas, Rosa M, Laguna-Muñoz, David, Jiménez-Peinado, Ana, Mannino, David, Vieta, Eduard, Sarramea, Fernando

Get full text

Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. P.0877 Lithium treatment influences blood transcriptome during manic but not depressive episode in bipolar patients” [European Neuropsychopharmacology 2021 53S1. S642] by Szczepankiewicz, O., Dmitrzak-Wȩglarz, M., Bilska, K., Kapelski, P., Nowakowska, J., Naro˙zna, B., Trze´sniowska-Drukała, B., Kalinowska, S., Twarowska-Hauser, J., Pawlak, J.

Get full text

Corrigendum to “P.1.g.013 - Stevens-Johnson syndrome induced by sodium valproate – a case report [European Neuropsychopharmacology Volume 27, Supplement 4, October 2017, Pages S645—S646]” by Nascimento, Sandra, Freitas, Filipa, Filipe, Teresa Prior, Pereira, Diana, Viveiros, Vânia, Costa, Cristina, Marques, João Gama, Prates, Marcelo

Get full text

Corrigendum to “Abstracts of the Virtual World Congress of Psychiatric Genetics (WCPG), October 11-15, 2021 - Oral abstracts. [European Neuropsychopharmacology 51 (2021) e40–e93]”

Get full text

Corrigendum to 'No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial' European Neuropsychopharmacology 53 (2021) 34-46 by Baune, Bernhard T, Sampson, Emma, Louise, Jennie, Hori, Hikaru, Schubert, K Oliver, Clark, Scott R, Mills, Natalie T, Fourrier, Célia

Get full text

Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy by Kane, J M, Aguglia, E, Altamura, A C, Ayuso Gutierrez, J L, Brunello, N, Fleischhacker, W W, Gaebel, W, Gerlach, J, Guelfi, J D, Kissling, W, Lapierre, Y D, Lindström, E, Mendlewicz, J, Racagni, G, Carulla, L S, Schooler, N R

Get full text

Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment by Millan, Mark J, Fone, Kevin, Steckler, Thomas, Horan, William P

Get full text

60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress by Millan, Mark J, Goodwin, Guy M, Hamon, M, Meyer-Lindenberg, Andreas, Ögren, Sven Ove

Get full text